ISMRM & ISMRT Annual Meeting & Exhibition • 03-08 June 2023 • Toronto, ON, Canada
16:00 |
Molecular Mechanisms of MRI Contrast
Eric Gale
Keywords: Contrast mechanisms: Relaxometry This talk will discuss the molecular mechanisms that underpin paramagnetic nuclear magnetic relaxation, and how these principles can be applied to more potent MRI contrast agents and biochemically specific probes for molecular MR imaging. An understanding of T1 and T2 relaxation, and how these properties relate to MRI contrast, is assumed. |
|
16:30 |
Techniques - commonly used pulse sequence for contrast enhanced
MRI
Yae Won Park
Keywords: Neuro: Brain, Contrast mechanisms: Perfusion, Education Committee: Clinical MRI Commonly used pulse sequences for contrast-enhanced MRI in brain tumors will be discussed in this lecture. Knowledge of underlying mechanism of contrast-enhanced MRI enhance our ability in diagnosis of brain tumors. |
|
17:00 |
Applications - what contrast agent to use and when
Masahiro Tanabe
Keywords: Contrast mechanisms: Contrast agents, Body: Liver The major classes of contrast agents currently used for magnetic resonance (MR) imaging of the liver include extracellular agents, hepatobiliary agents, and reticuloendothelial agents. This course will identify common clinical applications of contrast-enhanced imaging of the liver and what contrast agent is commonly used and when. We discuss properties of contrast agents, as well as their advantages and disadvantages, and present the recent research advances for improving this promising imaging method. Knowledge of these specific mechanisms, and typical and atypical enhancement pattern is important not only for accurate imaging-based diagnoses but also for understanding the pathogenesis of hepatic mass lesions. |
|
17:30 |
Contrast agents of the future
Célia Bonnet
Keywords: Contrast mechanisms: Contrast agents, Contrast mechanisms: Molecular imaging, Contrast mechanisms: Relaxometry This educational session will focus on the use of small metal complexes as MRI contrast agents, and more particularly on responsive contrast agents. T1, as well as ParaCEST, Parashift and non-proton (19F) contrast agents will be presented. Among all the physiological parameters that can be detected using such complexes, a particular emphasis will be put on enzymatically-activated, and zinc responsive contrast agents. Indeed, these two biomarkers are misregulated during pathological processes such as cancers, or neurodegenerative diseases for example. Monitoring their changes should allow, in principle, early diagnosis as they appear prior to the morphological changes they trigger. |
The International Society for Magnetic Resonance in Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.